We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Tess Stynes Pfizer Inc. (PFE) said the U.S. Food and Drug Administration will take three months more than initially expected to review the pharmaceutical company's application to market a new...
CARMIEL, Israel, Jan. 13 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE-Amex: PLX), announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency...
CHICAGO, Jan. 5 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for PFE, HPQ, AMAT, PPG, and AU. Seven Summits Strategic Investments' PriceWatch Alerts are available at...
Standard & Poor's said online travel agent Priceline.com Inc. (PCLN) will replace Schering-Plough Corp. (SGP) in the S&P 500 index once that pharmaceutical company is being acquired by...
Ecuador is to pay royalties to the holders of international pharmaceutical patents, basing the payments on the sale price of locally produced medicines, the Ecuadorian Institute of Intellectual...
(Adds details about company's rationale behind executive awards, beginning in 3rd paragraph; updates stock price, at end.) By Peter Loftus Of DOW JONES NEWSWIRES Pfizer Inc. (PFE) rewarded two top...
(Adds comments from Pfizer spokeswoman; updates stock price.) By Peter Loftus Of DOW JONES NEWSWIRES Pfizer Inc. (PFE) rewarded two top executives for helping to pull off the drug maker's $68...
By Peter Loftus Of DOW JONES NEWSWIRES Pfizer Inc. (PFE) rewarded two top executives for helping to pull off the drug maker's $68 billion acquisition of Wyeth earlier this month. Pfizer's board on...
Ecuador's President Rafael Correa has signed a decree to grant mandatory licenses for local laboratories to produce local medicines currently protected with patents, aiming to lower prices for...
Medivation Inc. (MDVN) signed a global partnership with Japanese pharmaceutical company Astellas Pharma Inc. (ALPMY) to develop and market the San Francisco company's experimental prostate cancer...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.006 | -23.0769230769 | 0.026 | 0.027 | 0.019 | 2562122 | 0.02193541 | DE |
4 | -0.007 | -25.9259259259 | 0.027 | 0.032 | 0.019 | 2219434 | 0.02399749 | DE |
12 | -0.006 | -23.0769230769 | 0.026 | 0.0325 | 0.019 | 1204693 | 0.02523642 | DE |
26 | -0.032 | -61.5384615385 | 0.052 | 0.053 | 0.019 | 788494 | 0.0277427 | DE |
52 | -0.041 | -67.2131147541 | 0.061 | 0.065 | 0.019 | 637212 | 0.03542577 | DE |
156 | -0.21 | -91.3043478261 | 0.23 | 0.24 | 0.019 | 281446 | 0.05548577 | DE |
260 | -0.24 | -92.3076923077 | 0.26 | 0.575 | 0.019 | 343021 | 0.14151836 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions